Brief: Nkarta Announces Positive Preliminary Dose Finding Data For Two Lead Engineered Natural Killer Cell Programs

Nkarta

25/04/2022 12:12

April 25 (Reuters) - Nkarta Inc  NKTX.O :
    * NKARTA ANNOUNCES POSITIVE PRELIMINARY DOSE FINDING DATA FOR TWO LEAD
ENGINEERED
NATURAL KILLER CELL PROGRAMS
    * NKARTA INC - IN BOTH TRIALS, NO DOSE LIMITING TOXICITY WAS OBSERVED AND
THERE
WERE NO CAR T LIKE ADVERSE EVENTS OF ANY GRADE
    * NKARTA INC - HIGHER DOSE REGIMEN OF 1.5 BILLION X 3 DOSES OF CAR NK CELLS
IS
BEING EVALUATED IN BOTH PROGRAMS
    * NKARTA INC - NO CYTOKINE RELEASE SYNDROME (CRS), NEUROTOXICITY OR GRAFT
VERSUS
HOST DISEASE (GVHD) REPORTED FOR EITHER PROGRAM

Source text for Eikon:  ID:nGNX4V9ZHz 
Further company coverage:  NKTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))